Opko Health Stock EBITDA
| OPK Stock | 587.50 5.30 0.89% |
Opko Health fundamentals help investors to digest information that contributes to Opko Health's financial success or failures. It also enables traders to predict the movement of Opko Stock. The fundamental analysis module provides a way to measure Opko Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Opko Health stock.
Opko |
Opko Health Company EBITDA Analysis
Opko Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Opko Health EBITDA | 35.8 M |
Most of Opko Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opko Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Opko Health reported earnings before interest,tax, depreciation and amortization of 35.8 M. This is 95.92% lower than that of the Healthcare sector and 93.92% lower than that of the Drug Manufacturers - Specialty & Generic industry. The ebitda for all Israel stocks is 99.08% higher than that of the company.
Opko EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opko Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics of similar companies.Opko Health is currently under evaluation in ebitda category among its peers.
Opko Fundamentals
| Return On Equity | -0.19 | |||
| Return On Asset | -0.0659 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.9 B | |||
| Shares Outstanding | 772.69 M | |||
| Shares Owned By Insiders | 45.87 % | |||
| Shares Owned By Institutions | 24.36 % | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 2.78 X | |||
| Revenue | 1.77 B | |||
| Gross Profit | 504.67 M | |||
| EBITDA | 35.8 M | |||
| Net Income | (30.14 M) | |||
| Cash And Equivalents | 207.25 M | |||
| Cash Per Share | 0.34 X | |||
| Total Debt | 187.9 M | |||
| Debt To Equity | 20.50 % | |||
| Current Ratio | 1.10 X | |||
| Book Value Per Share | 2.11 X | |||
| Cash Flow From Operations | 38.34 M | |||
| Earnings Per Share | (0.18) X | |||
| Number Of Employees | 5.77 K | |||
| Beta | 1.68 | |||
| Market Capitalization | 3.39 B | |||
| Total Asset | 2.4 B | |||
| Z Score | 10.8 | |||
| Net Asset | 2.4 B |
About Opko Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Opko Stock
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Opko Stock refer to our How to Trade Opko Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.